AdaptHealth
AHCO Β· Health Care Equipment
$6.02
2.4%Revvity
RVTY Β· Health Care Equipment
$158.77
0.9%The short version
- AdaptHealth is the larger business, with $3.2B of revenue in fiscal 2025 against $2.9B for Revvity.
- Revvity grew revenue faster (3.7%, against β0.5%).
- Revvity kept more of each dollar of sales as operating profit (12.5% operating margin, against 2.8% operating margin).
- Revvity turned more of its sales into free cash flow (17.8% FCF margin, against 6.8% FCF margin).
- Revvity earned a higher return on the capital invested in it (3.3%, against 2.1%).
| Latest fiscal year | AHCO Β· FY25 | RVTY Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $819M | $17.7B |
| Revenue | $3.2B | $2.9B |
| Free cash flow | $219M | $509M |
| Net income | β$70.8M | $241M |
| Growth | ||
| Revenue growth | β0.5% | 3.7% |
| 5-year growth | 25.2% | β5.5% |
| Share count change | β0.3% | β5.1% |
| Profitability | ||
| Gross margin | 18.8% | β |
| Operating margin | 2.8% | 12.5% |
| Net margin | β2.2% | 8.5% |
| FCF margin | 6.8% | 17.8% |
| Return on capital | 2.1% | 3.3% |
| Return on equity | β4.6% | 3.2% |
| Balance sheet | ||
| Net debt | $1.7B | $2.3B |
| Net debt / EBITDA | 3.6x | 3.0x |
| Dividends and buybacks | $0.0M | $854M |
| Valuation & quality | ||
| P/E | β | 76.0x |
| Piotroski F-score | 4 | 5 |
FY16
AHCO β
RVTY $2.1B
FY17
AHCO β
RVTY $2.3B
FY18
AHCO $345M
RVTY $2.8B
FY19
AHCO $530M
RVTY $2.9B
FY20
AHCO $1.1B
RVTY $3.8B
FY21
AHCO $2.5B
RVTY $3.8B
FY22
AHCO $3.0B
RVTY $3.3B
FY23
AHCO $3.2B
RVTY $2.8B
FY24
AHCO $3.3B
RVTY $2.8B
FY25
AHCO $3.2B
RVTY $2.9B
AHCO
RVTY
FY16
AHCO β
RVTY 13.9%
FY17
AHCO β
RVTY 13.1%
FY18
AHCO 9.0%
RVTY 11.7%
FY19
AHCO 5.6%
RVTY 12.6%
FY20
AHCO 6.8%
RVTY 22.9%
FY21
AHCO 9.2%
RVTY 32.9%
FY22
AHCO 6.4%
RVTY 22.4%
FY23
AHCO β18.7%
RVTY 10.9%
FY24
AHCO 8.1%
RVTY 12.6%
FY25
AHCO 2.8%
RVTY 12.5%
AHCO
RVTY
FY16
AHCO β
RVTY $319M
FY17
AHCO β
RVTY $249M
FY18
AHCO $58.5M
RVTY $218M
FY19
AHCO $39.1M
RVTY $287M
FY20
AHCO $156M
RVTY $829M
FY21
AHCO $72.4M
RVTY $1.3B
FY22
AHCO β$17.6M
RVTY $594M
FY23
AHCO $143M
RVTY $9.9M
FY24
AHCO $236M
RVTY $542M
FY25
AHCO $219M
RVTY $509M
AHCO
RVTY
FY16
AHCO β
RVTY 9.1%
FY17
AHCO β
RVTY 4.4%
FY18
AHCO β
RVTY 6.9%
FY19
AHCO 12.0%
RVTY 7.7%
FY20
AHCO 9.2%
RVTY 13.6%
FY21
AHCO 7.3%
RVTY 11.0%
FY22
AHCO 3.4%
RVTY 5.1%
FY23
AHCO β12.0%
RVTY 2.7%
FY24
AHCO 5.2%
RVTY 3.1%
FY25
AHCO 2.1%
RVTY 3.3%
AHCO
RVTY
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.